Skip to main content

iBNC Platform

iBNC platform,
the nanotechnology-based approach
for topical drug delivery

Our innovation and proprietary technology-iBNC (intelligence Bio-NanoCarrier) platform consists of nanotechnology and hydration enhancers, forming a surfactant-based nanocarrier.

Nano-based drug delivery systems
iBNC is designed to load/encapsulate active agents.

Strong hydration effects
iBNC with the strong capacity of hydration to promote the transdermal transport of both hydrophilic and lipophilic drugs.

Stabilize and target
Achieving the desired rate of release and the skin targeting by modifying permeation and penetration of active substances.

Multiple pathways permeate the skin
The functional platform can be fine-tuned to meet the requirements of the selected routes.

Delivery Technologies

The technology

Our delivery technologies enable many pharmaceutical products to improve patient health by enhancing the delivery of a therapeutic to its target site, minimizing off-target accumulation and facilitating patient compliance.

Expertise in

  • An agnostic evaluation of molecule, technology dose form, and manufacturing path.
  • Tailored and patented recommendations with options for optimal dose form selection.
  • Identification of development & manufacturing challenges.

Benefits

  • Increase patient initial acceptance and adherence.
  • Drive faster development timelines.
  • Enable a differentiated dose form to help develop a successful treatment in the marketplace.

Development Experience

Abounding experiences, those formula platforms we expertise.

Diseases Focus

Atopic Dermatitis

Atopic Dermatitis

Psoriasis

Psoriasis

Acne vulgaris

Acne vulgaris